James’ expertise spans various aspects of healthcare translation, including regulation, biomanufacturing, and intellectual property. James is programme coordinator and research associate of the CASMI Translational Stem Cell Consortium, where he is responsible for leading and
conducting research into and review of various aspects of regenerative medicine commercialisation. Prior to his current role, he received a research scholarship to Harvard University, where he investigated scale-up costs of exosomes under the supervision of Prof Jeff Karp and Brock Reeve. Before moving to the field of healthcare translation, he worked in the R&D department of an integrated supplier of micro-ingredients for
animal feeds, AB Vista, where he gained extensive experience applying advanced statistical methods in a commercial setting. James holds an EU Regulatory Affairs Certification (RAC, EU), the only globally recognised certification for the regulatory profession. He sits on the Publications Advisory Committee and is the lead author of several chapters published by the Regulatory Affairs Professionals Society, which is the largest global organisation of and for those involved with the regulation of healthcare and related products. He has also contributed to publications in several high impact academic journals, management journals and bioprocessing trade magazines on a range of topics. He has authored or co-authored several poster presentations, and regularly is regularly invited to speak
at a variety of international conferences. James holds a first class degree in biological sciences from the University of Oxford, where he was an academic scholar at Worcester College.